Lantheus Holdings LNTH
NASDAQ LNTH
$99.97 -0.27 (-0.27%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lantheus Holdings (LNTH) Change in Account Payables (2014 - 2026)

Lantheus Holdings (LNTH) posted quarterly Change in Account Payables of $190000.0 for Q1 2026, down 96.19% year-over-year from $5.0 million in Q1 2025, and up 100.59% quarter-over-quarter from -$32.0 million in Q4 2025.

Lantheus Holdings (LNTH) Change in Account Payables (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has reported Change in Account Payables for 13 consecutive years, with $190000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Change in Account Payables fell 96.19% year-over-year to $190000.0; the TTM figure through Mar 2026 stood at -$7.3 million (down 1923.33% YoY), while the FY2025 annual figure was -$2.5 million, up 71.69% from the prior year.
  • Change in Account Payables rose to $190000.0 in Q1 2026 per LNTH's latest filing, from -$32.0 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $20.1 million in Q3 2025 and bottomed at -$32.0 million in Q4 2025.
  • Historically, Change in Account Payables has averaged $375529.4 across 5 years, with a median of $1.5 million in 2022.
  • On a YoY basis, Change in Account Payables climbed as much as 933.63% in 2022 and fell as far as 1349.31% in 2022.
  • Lantheus Holdings' Change in Account Payables stood at -$8.1 million in 2022, then surged by 162.15% to $5.0 million in 2023, then sank by 297.56% to -$10.0 million in 2024, then plunged by 221.09% to -$32.0 million in 2025, then soared by 100.59% to $190000.0 in 2026.
  • Business Quant data shows LNTH's Change in Account Payables at $190000.0 in Q1 2026, -$32.0 million in Q4 2025, and $20.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -53.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -143.74 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -21.20 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Lantheus Holdings 6.52 Bn 5.93 Bn 241.86 Mn 1.39 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.39 Mn
Jun 30, 2026 1.39 Mn
Mar 31, 2026 190,000.00
Mar 31, 2026 190,000.00
Dec 31, 2025 -31.97 Mn
Dec 31, 2025 -31.97 Mn
Sep 30, 2025 20.11 Mn
Sep 30, 2025 20.11 Mn
Jun 30, 2025 4.38 Mn
Jun 30, 2025 4.38 Mn
Mar 31, 2025 4.98 Mn
Mar 31, 2025 4.98 Mn
Dec 31, 2024 -9.96 Mn
Dec 31, 2024 -9.96 Mn
Sep 30, 2024 -5.72 Mn
Sep 30, 2024 -5.72 Mn
Jun 30, 2024 10.34 Mn
Jun 30, 2024 10.34 Mn
Mar 31, 2024 -3.46 Mn
Mar 31, 2024 -3.46 Mn